Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Graft-versus-leukemia reactions after bone marrow transplantation
This map shows the geographic impact of C Rozmán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Rozmán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Rozmán more than expected).
This network shows the impact of papers produced by C Rozmán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Rozmán. The network helps show where C Rozmán may publish in the future.
Co-authorship network of co-authors of C Rozmán
This figure shows the co-authorship network connecting the top 25 collaborators of C Rozmán.
A scholar is included among the top collaborators of C Rozmán based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with C Rozmán. C Rozmán is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
López‐Guillermo, Armando, et al.. (1990). [Idiopathic myelofibrosis: clinical course, survival, and causes of death in a series of 60 patients].. PubMed. 35(2). 114–8.2 indexed citations
Estruch, Ramón, et al.. (1981). [Prolymphocyte T-cell leukemia: quantitative cytomorphological, cytochemical and ultrastructural study (author's transl)].. PubMed. 77(8). 311–7.1 indexed citations
15.
Grañena, A, et al.. (1979). [Bone marrow lymphoid follicles in myelofibrosis compared with chronic myelogenous leukaemia (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 21(3). 251–6.2 indexed citations
16.
Grañena, A, et al.. (1978). [The effectiveness of granulocyte transfusions in the treatment of severe injections in granulocytopenic patients. A controlled trial (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 23(3). 291–7.2 indexed citations
17.
Morey, M., C Rozmán, Evarist Feliú, et al.. (1977). [Interest of the staging of chronic lymphocytic leukaemia (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 22(5B). 901–11.3 indexed citations
18.
Woessner, S, et al.. (1976). [Ultrastructural aspects of dyserythropoiesis in the refractory anaemias (author's transl)].. PubMed. 21(3B). 670–82.2 indexed citations
Rozmán, C, et al.. (1964). [NASAL CARRIERS OF STAPHYLOCOCCUS AMONG THE STAFF OF VARIOUS MEDICAL INSTITUTIONS IN BARCELONA].. PubMed. 43. 17–9.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.